- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Asthma
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 766KB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 145KB)
Beclometasone with formoterol – March 2024
Beclometasone with Formoterol: Pressurised inhalation containing beclometasone dipropionate 100 micrograms and formoterol fumarate dihydrate 6 micrograms per dose,120 dose; Fostair®
Last updated
30 May 2025
